BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 15998784)

  • 1. The role of intramyocellular lipids during hypoglycemia in patients with intensively treated type 1 diabetes.
    Bernroider E; Brehm A; Krssak M; Anderwald C; Trajanoski Z; Cline G; Shulman GI; Roden M
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5559-65. PubMed ID: 15998784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective activation of skeletal muscle and adipose tissue lipolysis in type 1 diabetes mellitus during hypoglycemia.
    Enoksson S; Caprio SK; Rife F; Shulman GI; Tamborlane WV; Sherwin RS
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1503-11. PubMed ID: 12679430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glycemic control on target organ responses to epinephrine in type 1 diabetes.
    Aftab Guy D; Sandoval D; Richardson MA; Tate D; Davis SN
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E258-65. PubMed ID: 15784645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.
    Lucidi P; Rossetti P; Porcellati F; Pampanelli S; Candeloro P; Andreoli AM; Perriello G; Bolli GB; Fanelli CG
    Diabetes; 2010 Jun; 59(6):1349-57. PubMed ID: 20299466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gender on counterregulatory responses to euglycemic exercise in type 1 diabetes.
    Galassetti P; Tate D; Neill RA; Morrey S; Davis SN
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5144-50. PubMed ID: 12414885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans.
    Guy DA; Sandoval D; Richardson MA; Tate D; Flakoll PJ; Davis SN
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E178-86. PubMed ID: 15585598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of systemic, intramuscular, and subcutaneous adipose tissue lipolysis by insulin in humans.
    Stumvoll M; Jacob S; Wahl HG; Hauer B; Löblein K; Grauer P; Becker R; Nielsen M; Renn W; Häring H
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3740-5. PubMed ID: 11061533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation and counterregulation of lipolysis in vivo: different roles of sympathetic activation and insulin.
    Navegantes LC; Sjöstrand M; Gudbjörnsdottir S; Strindberg L; Elam M; Lönnroth P
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5515-20. PubMed ID: 14602799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis.
    Fanelli CG; De Feo P; Porcellati F; Perriello G; Torlone E; Santeusanio F; Brunetti P; Bolli GB
    J Clin Invest; 1992 Jun; 89(6):2005-13. PubMed ID: 1602007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes.
    Christensen M; Calanna S; Sparre-Ulrich AH; Kristensen PL; Rosenkilde MM; Faber J; Purrello F; van Hall G; Holst JJ; Vilsbøll T; Knop FK
    Diabetes; 2015 Jan; 64(1):72-8. PubMed ID: 25053587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ evidence that peripheral insulin resistance in adolescents with poorly controlled type 1 diabetes is associated with impaired suppression of lipolysis: a microdialysis study.
    Heptulla RA; Stewart A; Enocksson S; Rife F; Ma TY; Sherwin RS; Tamborlane WV; Caprio S
    Pediatr Res; 2003 May; 53(5):830-5. PubMed ID: 12702748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human skeletal muscle lipolysis is more responsive to epinephrine than to norepinephrine stimulation in vivo.
    Qvisth V; Hagström-Toft E; Enoksson S; Moberg E; Arner P; Bolinder J
    J Clin Endocrinol Metab; 2006 Feb; 91(2):665-70. PubMed ID: 16303838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans.
    Djurhuus CB; Gravholt CH; Nielsen S; Mengel A; Christiansen JS; Schmitz OE; Møller N
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E172-7. PubMed ID: 12067858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hepatic glycogen breakdown in defective counterregulation of hypoglycemia in intensively treated type 1 diabetes.
    Kishore P; Gabriely I; Cui MH; Di Vito J; Gajavelli S; Hwang JH; Shamoon H
    Diabetes; 2006 Mar; 55(3):659-66. PubMed ID: 16505228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of ghrelin administration on glucose and lipid metabolism.
    Vestergaard ET; Djurhuus CB; Gjedsted J; Nielsen S; Møller N; Holst JJ; Jørgensen JO; Schmitz O
    J Clin Endocrinol Metab; 2008 Feb; 93(2):438-44. PubMed ID: 18042651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a 3-day fast on regional lipid and glucose metabolism in human skeletal muscle and adipose tissue.
    Gjedsted J; Gormsen LC; Nielsen S; Schmitz O; Djurhuus CB; Keiding S; Ørskov H; Tønnesen E; Møller N
    Acta Physiol (Oxf); 2007 Nov; 191(3):205-16. PubMed ID: 17784905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal and metabolic counterregulation during and after high-dose insulin-induced hypoglycemia in diabetes mellitus type 2.
    Bischof MG; Ludwig C; Hofer A; Kletter K; Krebs M; Stingl H; Nowotny P; Waldhäusl W; Roden M
    Horm Metab Res; 2000 Oct; 32(10):417-23. PubMed ID: 11069207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus.
    Arbelaez AM; Xing D; Cryer PE; Kollman C; Beck RW; Sherr J; Ruedy KJ; Tamborlane WV; Mauras N; Tsalikian E; Wilson DM; White NH;
    Pediatr Diabetes; 2014 Mar; 15(2):127-34. PubMed ID: 23992543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycemia in T1DM.
    Zenz S; Mader JK; Regittnig W; Brunner M; Korsatko S; Boulgaropoulos B; Magnes C; Raml R; Narath SH; Eller P; Augustin T; Pieber TR
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1408-1417. PubMed ID: 29408994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral glutamate metabolism during hypoglycaemia in healthy and type 1 diabetic humans.
    Bischof MG; Brehm A; Bernroider E; Krssák M; Mlynárik V; Krebs M; Roden M
    Eur J Clin Invest; 2006 Mar; 36(3):164-9. PubMed ID: 16506960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.